MedTrace Logo

Pregnancy Outcomes After Breast Cancer in Young Women With Germline Pathogenic Variants in Genes Other Than BRCA

NCT07591532 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 2200

Last updated 2026-05-15

No results posted yet for this study

Summary

The present study aims to refine the understanding of the prognostic impact of pregnancy after breast cancer in young women harboring germline pathogenic variants in breast cancer susceptibility genes other than BRCA

Conditions

Sponsors & Collaborators

  • Jules Bordet Institute

    lead OTHER

Principal Investigators

  • Matteo Lambertini, MD, PhD · IRCCS Azienda Ospedaliera Metropolitana

  • Evandro de Azambuja, MD, PhD · Jules Bordet Institute

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-06-30
Primary Completion
2027-12-31
Completion
2030-12-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07591532 on ClinicalTrials.gov